Evogliptin: all 21 studies that test it
Page 1 of 1. Open to participants first (0), then studies with results posted, then the rest; newest registration first within each.
- Effects of Pioglitazone and Evogliptin on Hepatic Fibrosis in Patients With Chronic Hepatitis B With Type 2 DiabetesStatus unknownNCT05473806Phase 4
- A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)TerminatedNCT05143177Phase 2/3
- A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and DapagliflozinStatus unknownNCT04706637Phase 4
- A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mgStatus unknownNCT04653779Phase 4
- Randomized, Open-label Trial of Inhibitory Effect of Evogliptin on Progression of CAVDStatus unknownNCT04521452Phase 4
- The Pharmacokinetics/Pharmacodynamics and Safety/Tolerability of Evogliptin in Hemodialysis PatientsCompletedNCT04195919Phase 1
- Efficacy and Safety of Evogliptin When Added to Ongoing Metformin and Dapagliflozin Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic ControlCompletedNCT04170998Phase 3
- Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVDCompletedNCT04055883Phase 2
- Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver DiseasesCompletedNCT03910361Phase 4
- Effect of Evogliptin on Albuminuria in Patients With Type 2 Diabetes and Renal InsufficiencyCompletedNCT03667300Phase 2
- Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)CompletedNCT02974504Phase 4
- Efficacy and Safety of Evogliptin add-on to Metformin in Patients With type2 DiabetesCompletedNCT02949193Phase 3
- A Clinical Trial to Investigate the Efficacy and Safety of EvogliptinCompletedNCT02946541Phase 3
- Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic DysfunctionCompletedNCT02754219Phase 1
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mgCompletedNCT02753803Phase 1
- Evogliptin in Type 2 Diabetes Mellitus (EVOLUTION: EVOgLiptina no Diabetes Mellitus TIpO 2)CompletedNCT02689362Phase 2
- Effect of Evogliptin on Bone Metabolism in HumanStatus unknownNCT02587975Phase 4
- Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229Status unknownNCT02267902Phase 1
- PK//PD/Tolerability Study of DA-1229(Evogliptin) in Renal Impaired PatientsCompletedNCT02214693Phase 1
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male SubjectsCompletedNCT01941199Phase 1
- A Study to Characterize the Pharmacokinetics/Pharmacodynamics and Effect of Food of DA-1229 in Healthy Male SubjectsStatus unknownNCT00961025Phase 1